Tag: MMM

Blue Horseshoe Stocks: Wrapping Another Great Week

Options Review
–
It has been another characteristically good week for the options ideas we’ve been tracking, including a pair of twenty-baggers on Wednesday. To follow up on that, we presented some fresh targets in yesterdays report, and we got some good results from those as well.

Here were top movers and the total potential gains they produced on the day:

Anheuser Busch InBev BUD Weekly $99-101 Calls 

$99 Calls – Range: .56-3.40 – Max Gain: 507%
$100 Calls – Range: .40-2.67 – Max Gain: 568%
$101 Calls – Range: .26-1.55 – Max Gain: 496%

3M Corp. MMM Weekly $185-190 Calls 

$85 Calls – Range: 1.10-2.15 – Max Gain: 95%
$87.50 Calls – Range: .40-.92 – Max Gain: 130%
$90 Calls – Range: .14-.28 – Max Gain: 100%
_____

Fresh Ideas:
Twitter, Inc. TWTR Weekly $38.50-41 Calls*
Starbucks, Inc. SBUX Weekly $95.50-96.50 Calls*
SPDR S&P500 (ETF) SPY Weekly $300-301 Calls*

* Do not attempt to trade options with a weekly expiration on Friday unless you are an advanced level trader with access to disposable funds.


Other Updates 

Fuel Cell Energy Inc. FCEL – We wanted to mention the bottom bounce candidate we tagged in yesterday’s watchlist. It was looking ripe for another rebound and we ultimately saw the beginnings of that.

The stock traded up from a daily low of .365, and reached a high of .4926. That works out to an intraday move of 35% and a good start for a play that we’re going to continue to track.


____

Tautachrome, Inc. TTCM – Has made repeat appearances in our reports recently, because of the solid intraday volatility it has been bringing to the table and yesterday was no exception.

The stock had another nice bounce back with a range of .0161-.0245, representing a daily move of 52%

Extended Watchist:
MAT, NXGN, SMSI, PCTL,

Blue Horseshoe Stocks: THC Explosion


Tenet Healthcare Corp. THC – Options Explode

We included a fresh options trading idea for THC in yesterday morning’s premarket report. The stock was exhibiting the characteristics of a potential bottom bounce play, and we signaled the THC Weekly $18-18.50 Calls to correlate with the possible rebound.

We got just what we were looking for, however, with far greater single-session figured than we could have imagined. The results were two of the best intraday gain possibilities that we’ve identified in 2019, tipping the scales with twenty-bagger status!

$18 Calls – Range: .10-2.14 – Max Gain: 2040%
$18.50 Calls – Range: .05-1.52 – Max Gain: 2940%

Updated Idea: THC Weekly $19.50-20 Calls 

PCT Ltd. PCTL 

For another quick update on PCTL, the OTC play we’ve been tracking, yesterday the stock registered new highs for the third time this week.

PCTL traded in a range from .017 to .029, for an intraday rip of 71% which also represented a total increase of 226% over our .0089 observed low following our initial alert on Monday morning.

Fresh Options Ideas:
SPY Weekly $301-302 Calls
BUD Weekly $99-101 Calls
MMM Weekly $185-190 Calls

Extended Watchist:
NOK, AZN, MYSZ, FCEL, LPTX, GHDX, UPS, DPW

Blue Horseshoe Stocks: MMM Update & More

3M Co. MMM – Update

Fresh for yesterday morning’s report, we decided to highlight some MMM calls on the heels of the company’s earnings report, so we put the MMM Weekly $195-202.50 Calls on the radar.

Thanks to a solid intraday performance wherein the stock ran from a low of 194.20-199.89, there were some huge intraday moves from for traders to take advantage of promptly following the opening bell, which were as follows:

$195 Calls – Range: 2.24-6.00 – Max Gain: 168%
$197.50 Calls – Range: .67-4.34 – Max Gain: 548%
$200 Calls – Range: .71-2.80 – Max Gain: 294%
$202.50 Calls – Range: .27-1.55 – Max Gain: 474%

_____

Fresh Options Ideas:
AAPL Weekly $160-162.50 Calls
SPY Weekly $264-265.50 Calls


TrovaGene, Inc. TROV – Review

We last mentioned TROV on December 18th, and at the time the stock was trading down to an annual low of .503. Since then, we’ve seen a slow and steady recovery, which was kicked into a higher gear yesterday following news of Trovagene and PoC Capital entering an agreement to fund the development of Onvansertib in Metastatic Colorectal Cancer.

The stock ended up hitting .73, marking a 45% rise since we mentioned it. We will want to continue monitoring TROV for further advances from this point forward.

Extended Watchlist:
STAF, CREG, CRMD, EKSO, RGS, CLF, TOPS, WFT, ZYNE, IBN